Quanterix Corp
(NAS:QTRX)
$
11.06
-0.01 (-0.09%)
Market Cap: 426.08 Mil
Enterprise Value: 169.82 Mil
PE Ratio: 0
PB Ratio: 1.26
GF Score: 71/100 Quanterix Corp at Barclays Global Healthcare Conference Transcript
Mar 15, 2022 / 02:45PM GMT
Release Date Price:
$24.05
(+3.40%)
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst
All right. Good morning, everybody. Good morning. My name is Luke Sergott. I cover life science tools and diagnostics. I have with me Kevin Hrusovsky and Masoud Toloue of Quanterix. Kind of get your names right.
E. Kevin Hrusovsky
Quanterix Corporation - Chairman & CEO
That was pretty good, Luke.
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst
It was pretty close. There's a lot of confidence there leading off. So I guess you guys want to go over a couple of slides here if you want to go over and then we'll dig into some Q&A.
E. Kevin Hrusovsky
Quanterix Corporation - Chairman & CEO
Yes. So maybe just to start off, if much of -- just from the standpoint of Quanterix, it's really great to be here first, Luke. And I do think that this is a very pivotal moment for our company. We're at a very important, inflection point given the Lilly deal that we were
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot